SimPath is dedicated to helping researchers reduce their costs and time spent designing and building DNA. Thanks to Synthetic Biology, a revolution in manufacturing and producing goods is upon us. Businesses and academic labs are using bacteria, yeast, and plants to grow their own material goods, such as medicine, fuel, chemicals, and food.
Sustainable | Innovative | Cost Effective
The process known as biomanufacturing is quickly taking the market by storm. Sustainably innovative, quick, and less expensive than traditional methods, biomanufacturing is the way of the future. It’s ability to disrupt the market with new products has attracted new players to the industry and has R&D divisions actively exploring new ideas.
To meet this growing demand, scientists are using Synthetic Biology to accelerate their “design-build-test” cycles in order to bring new products to the market faster. With 190 Synthetic Biology companies in the U.S. and over $1B spent on funding startups, the success of this method is undeniable.
The Synthetic Biology industry is growing in the United States
Unfortunately, a bottleneck still exists in R&D’s design and build stages, leading to increased costs and research slowdowns. That’s where SimPath steps in. We streamline these stages for scientists— allowing them to test hundreds of ideas in less time and at a similar or lower cost as existing technology. If you’re struggling through this process, we want you to know you don’t have to. Instead, just take the simple path to innovation with SimPath.